Literature DB >> 22864806

Familial colon cancer syndromes: an update of a rapidly evolving field.

Swati G Patel1, Dennis J Ahnen.   

Abstract

Colorectal cancer (CRC) is a major cause of morbidity and mortality in the world. Up to 30 % of CRCs have evidence of a familial component, and about 5 % are thought to be due to well-characterized inherited mutations. This review will focus on recent developments in the understanding of the individual hereditary CRC syndromes, including Lynch syndrome, familial CRC type X, familial adenomatous polyposis, MutYH-associated polyposis, Peutz-Jeghers syndrome, juvenile polyposis syndrome, PTEN hamartomatous syndrome, and serrated polyposis syndrome. Advances within the area of hereditary colon cancer syndromes paint a picture of a rapidly moving, rapidly maturing, and increasingly collaborative field with many opportunities for ongoing research and development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22864806      PMCID: PMC3448005          DOI: 10.1007/s11894-012-0280-6

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  59 in total

Review 1.  Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome.

Authors:  Noralane M Lindor
Journal:  Surg Oncol Clin N Am       Date:  2009-10       Impact factor: 3.495

Review 2.  [Peutz-Jeghers' syndrome with malignant development in a hamartomatous polyp: report of one case and review of the literature].

Authors:  S Bouraoui; H Azouz; H Kechrid; F Lemaiem; S Mzabi-Regaya
Journal:  Gastroenterol Clin Biol       Date:  2008-03-04

3.  Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.

Authors:  Elena Stoffel; Bhramar Mukherjee; Victoria M Raymond; Nabihah Tayob; Fay Kastrinos; Jennifer Sparr; Fei Wang; Prathap Bandipalliam; Sapna Syngal; Stephen B Gruber
Journal:  Gastroenterology       Date:  2009-07-18       Impact factor: 22.682

4.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

Authors:  Marjolijn J L Ligtenberg; Roland P Kuiper; Tsun Leung Chan; Monique Goossens; Konnie M Hebeda; Marsha Voorendt; Tracy Y H Lee; Danielle Bodmer; Eveline Hoenselaar; Sandra J B Hendriks-Cornelissen; Wai Yin Tsui; Chi Kwan Kong; Han G Brunner; Ad Geurts van Kessel; Siu Tsan Yuen; J Han J M van Krieken; Suet Yi Leung; Nicoline Hoogerbrugge
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

5.  Increased cyclooxygenase-2 expression in juvenile polyposis syndrome.

Authors:  W Arnout van Hattem; Lodewijk A A Brosens; Susan Y Marks; Anya N A Milne; Susanne van Eeden; Christine A Iacobuzio-Donahue; Ari Ristimäki; Francis M Giardiello; G Johan A Offerhaus
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-05       Impact factor: 11.382

6.  Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis.

Authors:  Karam S Boparai; Evelien Dekker; Susanne Van Eeden; Mirjam M Polak; Joep F W M Bartelsman; Elisbeth M H Mathus-Vliegen; Josbert J Keller; Carel J M van Noesel
Journal:  Gastroenterology       Date:  2008-09-20       Impact factor: 22.682

7.  Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study.

Authors:  Sean P Cleary; Michelle Cotterchio; Mark A Jenkins; Hyeja Kim; Robert Bristow; Roger Green; Robert Haile; John L Hopper; Loic LeMarchand; Noralane Lindor; Patrick Parfrey; John Potter; Ban Younghusband; Steven Gallinger
Journal:  Gastroenterology       Date:  2008-12-27       Impact factor: 22.682

8.  Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.

Authors:  Mark A Jenkins; Shinichi Hayashi; Anne-Marie O'Shea; Lawrence J Burgart; Tom C Smyrk; David Shimizu; Paul M Waring; Andrew R Ruszkiewicz; Aaron F Pollett; Mark Redston; Melissa A Barker; John A Baron; Graham R Casey; James G Dowty; Graham G Giles; Paul Limburg; Polly Newcomb; Joanne P Young; Michael D Walsh; Stephen N Thibodeau; Noralane M Lindor; Loïc Lemarchand; Steven Gallinger; Robert W Haile; John D Potter; John L Hopper; Jeremy R Jass
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

9.  Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

Review 10.  PTEN hamartoma tumor syndrome: an overview.

Authors:  Judith A Hobert; Charis Eng
Journal:  Genet Med       Date:  2009-10       Impact factor: 8.822

View more
  51 in total

1.  Rates of Actionable Genetic Findings in Individuals with Colorectal Cancer or Polyps Ascertained from a Community Medical Setting.

Authors:  Adam S Gordon; Elisabeth A Rosenthal; David S Carrell; Laura M Amendola; Michael O Dorschner; Aaron Scrol; Ian B Stanaway; Shannon DeVange; James D Ralston; Hana Zouk; Heidi L Rehm; Eric Larson; David R Crosslin; Kathy A Leppig; Gail P Jarvik
Journal:  Am J Hum Genet       Date:  2019-08-15       Impact factor: 11.025

2.  Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes.

Authors:  Helle Vendel Petersen; Birgitte Lidegaard Frederiksen; Charlotte Kvist Lautrup; Lars Joachim Lindberg; Steen Ladelund; Mef Nilbert
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

3.  Moving the Needle on Action Around Evidence-Based Screening for Hereditary Conditions: Preparing State Chronic Disease Directors to Advance Precision Public Health.

Authors:  Amy Ponte; Samantha Greenberg; Karen Greendale; Laura Senier
Journal:  Public Health Rep       Date:  2019-03-21       Impact factor: 2.792

4.  Rectal cancer: a truly multidisciplinary challenge.

Authors:  Timothy D Wagner
Journal:  J Gastrointest Oncol       Date:  2014-10

5.  Rare loss of function variants in candidate genes and risk of colorectal cancer.

Authors:  Elisabeth A Rosenthal; Brian H Shirts; Laura M Amendola; Martha Horike-Pyne; Peggy D Robertson; Fuki M Hisama; Robin L Bennett; Michael O Dorschner; Deborah A Nickerson; Ian B Stanaway; Rami Nassir; Kathy T Vickers; Christopher Li; William M Grady; Ulrike Peters; Gail P Jarvik
Journal:  Hum Genet       Date:  2018-09-28       Impact factor: 4.132

6.  Development of FamilyTalk: an Intervention to Support Communication and Educate Families About Colorectal Cancer Risk.

Authors:  Deborah J Bowen; Travis Hyams; Mercy Laurino; Timothy Woolley; Stacey Cohen; Kathleen A Leppig; Gail Jarvik
Journal:  J Cancer Educ       Date:  2020-06       Impact factor: 2.037

Review 7.  The emerging role of QSOX1 in cancer.

Authors:  Douglas F Lake; Douglas O Faigel
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 8.  Hereditary diffuse gastric cancer: What the clinician should know.

Authors:  Ryan Ying Cong Tan; Joanne Ngeow
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

9.  Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP.

Authors:  Rachel A Levy; Vanessa W Hui; Rupa Sood; Stephanie Fish; Arnold J Markowitz; Richard J Wong; José G Guillem
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

10.  Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing.

Authors:  H Wu; X-Y Zhang; Z Hu; Q Hou; H Zhang; Y Li; S Li; J Yue; Z Jiang; S M Weissman; X Pan; B-G Ju; S Wu
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.